Gardiner Healthcare Acquisitions Corp. Warrant
GDNRW
GDNRW was delisted on the 15th of December, 2023.
0 hedge funds and large institutions have $0 invested in Gardiner Healthcare Acquisitions Corp. Warrant in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 26 closing their positions.
100% less funds holding
Funds holding: 26 → 0 (-26)
100% less capital invested
Capital invested by funds: $4.04M → $0 (-$4.04M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 26
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$3.8M |
| 2 |
EFI
EHP Funds Inc
Toronto,
Canada
|
-$51.3K |
| 3 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
-$33K |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$25.8K |
| 5 |
ASM
ATW SPAC Management
New York
|
-$22.7K |
GDNRW Hedge Fund Activity: Q4 2023 in Review
0 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Gardiner Healthcare Acquisitions Corp. Warrant (GDNRW) for Q4 2023, worth a combined $0 — down 100% from $4.04M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of GDNRW and 0 opened new positions — a net loss of 26 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Boothbay Fund Management, exiting entirely with an estimated $3.8M sold.
- 0 institutional investors held Gardiner Healthcare Acquisitions Corp. Warrant (GDNRW) as of Q4 2023, down from 26 in Q3 2023.
- Funds reported $0 of Gardiner Healthcare Acquisitions Corp. Warrant stock for Q4 2023, down 100% quarter-over-quarter.
- 0 funds opened new Gardiner Healthcare Acquisitions Corp. Warrant positions in Q4 2023 and 26 closed out, a net change of -26 holders.
- The largest Gardiner Healthcare Acquisitions Corp. Warrant seller in Q4 2023 was Boothbay Fund Management, an estimated $3.8M sold.
Based on aggregated 13F filings for Q4 2023.